SCHEMBL7989422

SCHEMBL7989422

O=c1nc(-c2cccnc2)[nH]c2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 2/20 0.42
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 1/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2B Q13224 2/20 0.41
GPR55 Q9Y2T6 1/20 0.40
PARN O95453 1/20 0.39
DHPS P49366 1/20 0.39
CLK1 P49759 1/20 0.39
DYRK1A Q13627 1/20 0.39
HTT P42858 1/20 0.38
KMT2A Q03164 1/20 0.38
ELOVL1 Q9BW60 1/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 1/20 0.38
NPY5R Q15761 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7974289 0.90 CNOT7 (0.53) CNOT7SMN1; SMN2PARNDHPSCLK1
SCHEMBL7984771 0.90 CNOT7 (0.47) CNOT7SMN1; SMN2GRIN1GRIN2BPARN
SCHEMBL7985337 0.89 CNOT7 (0.48) CNOT7CYP11B1GRIN1GRIN2BCLK1
SCHEMBL7986522 0.88 CNOT7 (0.48) CNOT7SMN1; SMN2CYP11B1CYP11B2PARN
SCHEMBL7985279 0.87 CNOT7 (0.49) CNOT7SMN1; SMN2PARNDYRK1AHTT
SCHEMBL7974239 0.87 CNOT7 (0.45) CNOT7PARNDHPSCLK1DYRK1A
SCHEMBL7984283 0.87 CNOT7 (0.43) CNOT7SMN1; SMN2PKMCYP11B2PARN
SCHEMBL7988736 0.85 ACP1 (0.45) CNOT7SMN1; SMN2CYP11B1CYP11B2GRIN1
SCHEMBL7988666 0.85 CNOT7 (0.48) CNOT7SMN1; SMN2GRIN1GRIN2BPARN
SCHEMBL7985119 0.84 CNOT7 (0.42) CNOT7SMN1; SMN2HTTKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed